Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market

Go back to Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.76 -0.07 (8.43%)
Previous Close $0.83    52 Week High $9.58 
Open $0.85    52 Week Low $2.34 
Day High $0.90    P/E N/A 
Day Low $0.71    EPS $-0.34 
Volume 1,313,208